new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
November 2000
                                    
                                    Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.
The new tabs come in two strengths...35 and 70 mg.
Patients taking 5 mg/d to prevent osteoporosis use the 35 mg tab.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
 - Quick, practical reference charts and tools
 - Comprehensive CE library to meet license renewal and state requirements
 - Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
 - Plus much more!
 
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote